Stocks
Amylyx Pharmaceuticals (AMLX) ROE US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | 58.4% | 67.2% | 58.1% | -58.2% | 11.4% | -132.2% | ||
| Changes by years, y/y, % | +9pp | -9pp | -116pp | +70pp | -33.6% | ||||
Amylyx Pharmaceuticals. ROE, %
Amylyx Pharmaceuticals. ROE, changes, pp
Amylyx Pharmaceuticals (AMLX) ROE US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| ROE, % | ? | 0.44% | 11.4% | -21.9% | -63.5% | -132.2% | -132.2% | |
| Changes by years, y/y, % | +170pp | +70pp | +20pp | -45pp | -133pp | |||
| Changes by quarters, q/q, % | +19pp | +11pp | -33pp | -42pp | -69pp | |||
